BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 386707)

  • 1. Immunopathology of the glomerular changes in chronic pyelonephritis.
    Yonezawa S
    Acta Pathol Jpn; 1979 Sep; 29(5):677-85. PubMed ID: 386707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glomerular immunopathology: comparative study with immunofluorescence and immunoperoxidase (author's transl)].
    Vieira LM; Sarno EN; Ruzany F; De Lacerda PR
    Rev Bras Pesqui Med Biol; 1979 Dec; 12(6):377-81. PubMed ID: 396606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy.
    Tomino Y; Sakai H; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y
    Am J Nephrol; 1986; 6(3):187-92. PubMed ID: 3526892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deposits in human glomerulopathy. Fluorescent microscopy findings in 366 kidney biopsies correlated to symptoms, clinical course and immunosuppressive therapy.
    Larsen S; Brun C
    Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):321-33. PubMed ID: 393071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical demonstration of serum beta2-glycoprotein III in normal and diseased human glomeruli.
    Chase WH; Prochaska H
    Clin Immunol Immunopathol; 1976 Mar; 5(2):247-57. PubMed ID: 58748
    [No Abstract]   [Full Text] [Related]  

  • 7. Glomerular immune deposits in kidneys from patients with no clinical or light microscopic evidence of glomerulonephritis. Assessment of the influence of autolysis on identification of immunoglobulins and complement.
    Larsen S
    Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):313-9. PubMed ID: 393070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence staining for the detection of immunoglobulins and complement (C3) in dogs with renal disease.
    Aresu L; Pregel P; Bollo E; Palmerini D; Sereno A; Valenza F
    Vet Rec; 2008 Dec; 163(23):679-82. PubMed ID: 19060316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA glomerular deposits in renal disease.
    Berger J
    Transplant Proc; 1969 Dec; 1(4):939-44. PubMed ID: 4107073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunohistological aspects of nephropathy with minimal lesions].
    Barbiano di Belgioioso G; Busnach G; Galato R; Torti G; Andreola S; Surian M
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):235-43. PubMed ID: 901637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ACTH-induced renal glomerular lesion in the mouse: immunofluorescence microscopy.
    Feldman DL; Gorfien SF; Christian JJ
    J Pathol; 1983 Mar; 139(3):363-78. PubMed ID: 6300362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of immunofluorescent patterns in renal diseases.
    Valenzuela R; Deodhar SD
    Pathobiol Annu; 1980; 10():183-221. PubMed ID: 7003493
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IgG, IgM, and C3 in experimental murine IgA nephropathy.
    Emancipator SN; Lamm ME
    Semin Nephrol; 1987 Dec; 7(4):286-8. PubMed ID: 3328245
    [No Abstract]   [Full Text] [Related]  

  • 15. IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli.
    Russell MW; Mestecky J; Julian BA; Galla JH
    J Clin Immunol; 1986 Jan; 6(1):74-86. PubMed ID: 3514654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J; Markowitz GS; Bomback AS; Appel GB; Herlitz LC; Barry Stokes M; D'Agati VD
    Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of immunoglobulin depositions by immunofluorescence and/or immunoperoxidase (P-AP method) in patients with IgA nephropathy.
    Miura M; Tomino Y; Nomoto Y; Sakai H; Osamura Y
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):343-7. PubMed ID: 3334190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular C3 receptors in human renal disease.
    Pettersson EE; Bhan AK; Schneeberger EE; Collins AB; Colvin RB; McCluskey RT
    Kidney Int; 1978 Mar; 13(3):245-52. PubMed ID: 651124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical improvements in the immunoperoxidase study of renal biopsy specimens.
    Howie AJ; Gregory J; Thompson RA; Adkins MA; Niblett AJ
    J Clin Pathol; 1990 Mar; 43(3):257-9. PubMed ID: 2185285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.